Mon. Nov 28th, 2022
How the Chinese-owned Gland Pharma transformed from a small-time Heparin maker to complex injectable manufacturing Chinese promoters of company to dilute shares in what is going to be India’s biggest IPO. Srinivas Sadu, MD, tells Moneycontrol that the one big advantage of Gland is uniform quality standards, across geographies, unlike other companies